Multi-center clinical study on the effect of glycine for disorders of urine storage

Multi-center clinical study on the effect of glycine for disorders of urine storage - The effect of glycine for disorders of urine storage

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT1091220113

Enrollment

160

Registered

2013-03-01

Start date

2013-02-27

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overactive bladder, chronic prostatitis, interstitial cystitis, and nocturia

Interventions

Intervention type:DRUG Name of intervention:glycine Dose form / Japanese Medical Device Nomenclature:POWDER Route of administration / Site of application:ORAL Dose per administration:3g 3g 3g Dosing f

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Untreated patients with disorders of urine storage (overactive bladder, chronic prostatitis, interstitial cystitis, or nocturia), or, patients whose urine storage symptoms remain even after more than 8 weeks of treatment with oral drug therapy

Exclusion criteria

Exclusion criteria: Patients with untreated organic diseases of the lower urinary tract , patients with bacterial infections of the urinary tract, patients without bladder sense, patients with residual urine (more than 100ml)

Design outcomes

Primary

Measure	Time frame
Urinary frequency, urinary urgency, bladder pain	—

Secondary

Measure	Time frame
Sleep disorders	—

Countries

Japan

Contacts

Public ContactKimio Sugaya

Kitakami Central Hospital and Southern Knights' Laboratory LLP

sugaya@sklabo.com+81-98-936-5111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026